Virtus LifeSci Biotech Clinical Trials ETF
19 hedge funds and large institutions have $6.02M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.
Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
